The confirmation of Dr. Robert Califf as commissioner of the Food and Drug Administration (FDA) is the latest example of President Biden’s extreme commitment to promoting abortion on demand, no matter the human cost. While Califf’s nomination ultimately did prevail, the abortion issue deprived the Biden team of an easy path to victory. And since personnel is policy, the debate did much to expose the FDA’s role in expanding mail-order abortion drug use.

The abortion industry has been pushing for years to turn post offices and pharmacies across America into abortion centers. That push has kicked into overdrive since the Supreme Court announced it would hear the Dobbs case, the biggest legal challenge yet to Roe v. Wade. “The abortion pill” (Mifeprex) actually involves two drugs: mifepristone, which stops the unborn baby from absorbing the nutrients it needs to survive; and misoprostol, which induces labor to expel the body of the dead child. This is the workaround pro-abortion activists envision for a post-Roe world, with bureaucrats like Califf rubber-stamping their agenda.

Chemical abortions often occur in private homes far away from medical supervision, meaning women are left to self-abort and cope with any harrowing complications — including potentially life-threatening bleeding or infection — on their own. Those in the abortion industry tout this as providing “convenience,” not mentioning that the wide availability of such dangerous drugs also boosts their profit margins, reduces the need for brick-and-mortar facilities, and allows them to wash their hands of responsibility for the patient far more easily.